Search Results

Press Releases

RoslinCT and BOOST Pharma Announce Strategic Manufacturing Agreement to Advance Cell Therapy for Infants with Osteogenesis Imperfecta

January 7, 2026

·

4 min read

Press Releases

RoslinCT and Ayrmid Ltd. Announce Expansion of Strategic Partnership to Manufacture Omisirge® (omidubicel-onlv) for Second FDA-Approved Indication in Severe Aplastic Anemia (SAA)

December 16, 2025

·

3 min read

Press Releases

RoslinCT and Ayrmid Pharma Ltd. Announce Their Intent to Enter Into a Strategic Partnership to Manufacture FDA Approved Cell Therapy Omisirge® (omidubicel-onlv)

March 11, 2025

·

3 min read

Job Trends

RoslinCT to manufacture exagamglogene autotemcel (exa-cel) for Vertex Pharmaceuticals Inc following an extensive development collaboration

RoslinCT to manufacture exagamglogene autotemcel (exa-cel) for Vertex Pharmaceuticals Inc following an extensive development collaboration RoslinCT will manufacture world’s-first CRISPR-based therapy.

November 28, 2023

·

4 min read

Press Releases

RoslinCT Announces Appointment of Jessica Carmen as Chief Commercial Officer

November 5, 2024

·

3 min read

RoslinCT to manufacture first-ever US FDA approved CRISPR-based gene therapy CASGEVY™ (exagamglogene autotemcel)

RoslinCT to manufacture first-ever US FDA approved CRISPR-based gene therapy CASGEVY™ (exagamglogene autotemcel).

December 11, 2023

·

4 min read

Business

RoslinCT Boston Appoints Dean J. Morris, as Chief Operations Officer

RoslinCT, a leading contract development and manufacturing organization (CDMO) for Advanced Cell and Gene Therapies, is pleased to announce the appointment of Dean J. Morris as the Chief Operations Officer at their Boston facility.

October 3, 2023

·

3 min read

Business

RoslinCT Announces the Appointment of Dr. Derek Hei to its Scientific Advisory Board

RoslinCT, a leading contract development and manufacturing organization (CDMO) for Advanced Cell and Gene therapies, announced the appointment of Derek Hei, Ph.D., to its Scientific Advisory Board (SAB).

August 17, 2023

·

3 min read

Business

RoslinCT and Lykan Bioscience Announce Integration to Establish Global Advanced Cell and Gene Therapy CDMO Service Offerings

RoslinCT and Lykan Bioscience, two leading Contract Development and Manufacturing Organizations (CDMOs) in the Cell and Gene Therapy industry, announce their integration, creating a unified business that will operate under the RoslinCT brand.

June 5, 2023

·

3 min read

Business

RoslinCT and Lykan Bioscience Announce the Appointment of Dr. Michael Mendicino to its Scientific Advisory Board

RoslinCT and Lykan Bioscience, a leader in Contract Development and Manufacturing for cell therapies, announced the appointment of Michael Mendicino, Ph.D. to its Scientific Advisory Board.

January 10, 2023

·

3 min read